SCHEMBL129472

SCHEMBL129472

CCCC(=O)OCCCC(C)C

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
DGKA P23743 1/20 0.48
NAAA Q02083 1/20 0.44
HTR2C P28335 1/20 0.43
ALDH1A1 P00352 3/20 0.43
MAPT P10636 1/20 0.42
DNM1 Q05193 1/20 0.41
CYP3A4 P08684 1/20 0.41
TSHR P16473 1/20 0.41
ATM Q13315 1/20 0.41
TDP1 Q9NUW8 1/20 0.41
PRSS1 P07477 1/20 0.39
PRSS2 P07478 1/20 0.39
PRSS3 P35030 1/20 0.39
RAD52 P43351 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
ADRA2A P08913 1/20 0.38
ADRA1A P35348 1/20 0.38
LMNA P02545 3/20 0.37
FAAH O00519 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL332926 0.94 NAAA (0.47) DGKANAAAHTR2CALDH1A1MAPT
SCHEMBL9185977 0.92 NAAA (0.50) DGKANAAAHTR2CALDH1A1MAPT
SCHEMBL332710 0.92 NAAA (0.50) DGKANAAAHTR2CALDH1A1MAPT
SCHEMBL11071867 0.92 NAAA (0.50) DGKANAAAHTR2CALDH1A1MAPT
SCHEMBL17511723 0.92 NAAA (0.50) DGKANAAAHTR2CALDH1A1MAPT
SCHEMBL27750415 0.92 NAAA (0.50) DGKANAAAHTR2CALDH1A1MAPT
SCHEMBL20377189 0.90 DGKA (0.57) DGKANAAAHTR2CALDH1A1MAPT
SCHEMBL10654547 0.90 ADRA2A (0.46) DGKANAAAHTR2CMAPTTDP1
SCHEMBL8419689 0.89 DGKA (0.66) DGKANAAAHTR2CALDH1A1MAPT
SCHEMBL322130 0.88 DGKA (0.52) DGKAALDH1A1MAPTDNM1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110981873-B Preparation method for synthesizing pyrroloquinoline quinone by five-step method 江西农业大学 2025-01-24 CN claimed
CN-110981873-B Preparation method for synthesizing pyrroloquinoline quinone by five-step method 江西农业大学 2025-01-24 CN disclosed
EP-3839028-B1 CLEANING PRODUCT PROCTER & GAMBLE (US) 2025-01-15 EP disclosed
EP-4386075-A2 CLEANING PRODUCT The Procter & Gamble Company (US) 2024-06-19 EP disclosed
US-11834629-B2 Cleaning product THE PROCTER & GAMBLE COMPANY (US) 2023-12-05 US disclosed
US-11834627-B2 Cleaning product THE PROCTER & GAMBLE COMPANY (US) 2023-12-05 US disclosed
EP-4124651-B1 CLEANING PRODUCT PROCTER & GAMBLE (US) 2023-11-29 EP disclosed
US-11822244-B2 Compound, resin, resist composition and method for producing resist pattern SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-11-21 US disclosed
US-20230314941-A1 CARBOXYLATE, CARBOXYLIC ACID GENERATOR, RESIN, RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-10-05 US disclosed
US-11753604-B2 Cleaning product THE PROCTER & GAMBLE COMPANY (US) 2023-09-12 US disclosed
US-20160062234-A1 RESIST COMPOSITION AND METHOD FOR PRODUCING RESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-03-03 US disclosed
US-20150241769-A1 PHOTORESIST COMPOSITION, COMPOUND AND PROCESS OF PRODUCING PHOTORESIST PATTERN SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-08-27 US disclosed
US-20150212407-A1 SALT AND PHOTORESIST COMPOSITION COMPRISING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-07-30 US disclosed
US-20150212408-A1 SALT AND PHOTORESIST COMPOSITION COMPRISING THE SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-07-30 US disclosed
US-8450319-B2 Pyrrolopyridazinone compound UBE INDUSTRIES, LTD. (JP) 2013-05-28 US disclosed
EP-1982986-B1 PYRROLOPYRIDAZINONE COMPOUND AS PDE4 INHIBITOR UBE INDUSTRIES (JP) 2012-03-07 EP disclosed
US-20090036453-A1 Pyrrolopyridazinone Compound UBE INDUSTRIES, LTD. (JP) 2009-02-05 US disclosed
EP-1982986-A1 PYRROLOPYRIDAZINONE COMPOUND Ube Industries, Ltd. (JP) 2008-10-22 EP disclosed
US-7157062-B2 Inhibition of the depletion of metal values from pregnant lixiviant solutions GE BETZ, INC. (US) 2007-01-02 US disclosed
US-20030228245-A1 Inhibition of the depletion of metal values from pregnant lixiviant solutions GE BETZ, INC. (US) 2003-12-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150241769-A1 PHOTORESIST COMPOSITION, COMPOUND AND PROCESS OF PRODUCING PHOTORESIST PATTERN PSMB10, PUF60, RARA DGKA 1535/4885NAAA 942/4885HTR2C 4232/4885
US-11822244-B2 Compound, resin, resist composition and method for producing resist pattern RER1, AFF1, AFF4 DGKA 3584/4885NAAA 2282/4885HTR2C 2945/4885
US-20090036453-A1 Pyrrolopyridazinone Compound CBR3, CBR1, CYC1 DGKA 3277/4885NAAA 2716/4885HTR2C 87/4885
US-20150212407-A1 SALT AND PHOTORESIST COMPOSITION COMPRISING THE SAME HAX1, XBP1, AP1S1 DGKA 2891/4885NAAA 4504/4885HTR2C 2103/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.